These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
400 related articles for article (PubMed ID: 31939276)
1. Endosomolytic and Tumor-Penetrating Mesoporous Silica Nanoparticles for siRNA/miRNA Combination Cancer Therapy. Wang Y; Xie Y; Kilchrist KV; Li J; Duvall CL; Oupický D ACS Appl Mater Interfaces; 2020 Jan; 12(4):4308-4322. PubMed ID: 31939276 [TBL] [Abstract][Full Text] [Related]
2. Stimuli-responsive hybrid nanocarriers developed by controllable integration of hyperbranched PEI with mesoporous silica nanoparticles for sustained intracellular siRNA delivery. Prabhakar N; Zhang J; Desai D; Casals E; Gulin-Sarfraz T; Näreoja T; Westermarck J; Rosenholm JM Int J Nanomedicine; 2016; 11():6591-6608. PubMed ID: 27994460 [TBL] [Abstract][Full Text] [Related]
3. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery. Ma X; Zhao Y; Ng KW; Zhao Y Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533 [TBL] [Abstract][Full Text] [Related]
4. A mesoporous silica nanoparticle--PEI--fusogenic peptide system for siRNA delivery in cancer therapy. Li X; Chen Y; Wang M; Ma Y; Xia W; Gu H Biomaterials; 2013 Jan; 34(4):1391-401. PubMed ID: 23164421 [TBL] [Abstract][Full Text] [Related]
5. Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy. Wang Y; Xie Y; Li J; Peng ZH; Sheinin Y; Zhou J; Oupický D ACS Nano; 2017 Feb; 11(2):2227-2238. PubMed ID: 28165223 [TBL] [Abstract][Full Text] [Related]
6. Intracellular cleavable poly(2-dimethylaminoethyl methacrylate) functionalized mesoporous silica nanoparticles for efficient siRNA delivery in vitro and in vivo. Lin D; Cheng Q; Jiang Q; Huang Y; Yang Z; Han S; Zhao Y; Guo S; Liang Z; Dong A Nanoscale; 2013 May; 5(10):4291-301. PubMed ID: 23552843 [TBL] [Abstract][Full Text] [Related]
7. Redox-responsive mesoporous silica nanoparticles: a physiologically sensitive codelivery vehicle for siRNA and doxorubicin. Ma X; Teh C; Zhang Q; Borah P; Choong C; Korzh V; Zhao Y Antioxid Redox Signal; 2014 Aug; 21(5):707-22. PubMed ID: 23931896 [TBL] [Abstract][Full Text] [Related]
8. In Vitro Dose Studies on Chitosan Nanoplexes for microRNA Delivery in Breast Cancer Cells. Kaban K; Salva E; Akbuga J Nucleic Acid Ther; 2017 Feb; 27(1):45-55. PubMed ID: 27763825 [TBL] [Abstract][Full Text] [Related]
9. Sustained delivery of siRNA/mesoporous silica nanoparticle complexes from nanofiber scaffolds for long-term gene silencing. Pinese C; Lin J; Milbreta U; Li M; Wang Y; Leong KW; Chew SY Acta Biomater; 2018 Aug; 76():164-177. PubMed ID: 29890267 [TBL] [Abstract][Full Text] [Related]
10. Periodic Mesoporous Ionosilica Nanoparticles for Green Light Photodynamic Therapy and Photochemical Internalization of siRNA. Mezghrani B; Ali LMA; Richeter S; Durand JO; Hesemann P; Bettache N ACS Appl Mater Interfaces; 2021 Jun; 13(25):29325-29339. PubMed ID: 34138540 [TBL] [Abstract][Full Text] [Related]
11. Endosomal escape kinetics of mesoporous silica-based system for efficient siRNA delivery. Wang M; Li X; Ma Y; Gu H Int J Pharm; 2013 May; 448(1):51-7. PubMed ID: 23524121 [TBL] [Abstract][Full Text] [Related]
12. Delivery of dual miRNA through CD44-targeted mesoporous silica nanoparticles for enhanced and effective triple-negative breast cancer therapy. Ahir M; Upadhyay P; Ghosh A; Sarker S; Bhattacharya S; Gupta P; Ghosh S; Chattopadhyay S; Adhikary A Biomater Sci; 2020 May; 8(10):2939-2954. PubMed ID: 32319481 [TBL] [Abstract][Full Text] [Related]
13. Co-Delivery of Epirubicin and siRNA Using Functionalized Mesoporous Silica Nanoparticles Enhances In vitro and In vivo Drug Efficacy. Hanafi-Bojd MY; Jaafari MR; Ramezanian N; Abnous K; Malaekeh-Nikouei B Curr Drug Deliv; 2016; 13(7):1176-1182. PubMed ID: 26718488 [TBL] [Abstract][Full Text] [Related]
14. siRNA-loaded poly(histidine-arginine) Sun P; Huang W; Kang L; Jin M; Fan B; Jin H; Wang QM; Gao Z Int J Nanomedicine; 2017; 12():3221-3234. PubMed ID: 28458542 [TBL] [Abstract][Full Text] [Related]
15. Delivery of miR-200c-3p Using Tumor-Targeted Mesoporous Silica Nanoparticles for Breast Cancer Therapy. Garrido-Cano I; Adam-Artigues A; Lameirinhas A; Blandez JF; Candela-Noguera V; Lluch A; Bermejo B; Sancenón F; Cejalvo JM; Martínez-Máñez R; Eroles P ACS Appl Mater Interfaces; 2023 Aug; 15(32):38323-38334. PubMed ID: 37549382 [TBL] [Abstract][Full Text] [Related]
16. Mesoporous silica nanoparticle delivery of chemically modified siRNA against TWIST1 leads to reduced tumor burden. Finlay J; Roberts CM; Dong J; Zink JI; Tamanoi F; Glackin CA Nanomedicine; 2015 Oct; 11(7):1657-66. PubMed ID: 26115637 [TBL] [Abstract][Full Text] [Related]
17. One-pot synthesis of pH-responsive hybrid nanogel particles for the intracellular delivery of small interfering RNA. Khaled SZ; Cevenini A; Yazdi IK; Parodi A; Evangelopoulos M; Corbo C; Scaria S; Hu Y; Haddix SG; Corradetti B; Salvatore F; Tasciotti E Biomaterials; 2016 May; 87():57-68. PubMed ID: 26901429 [TBL] [Abstract][Full Text] [Related]
18. Co-Delivery of Doxorubicin and Survivin shRNA-Expressing Plasmid Via Microenvironment-Responsive Dendritic Mesoporous Silica Nanoparticles for Synergistic Cancer Therapy. Li Z; Zhang L; Tang C; Yin C Pharm Res; 2017 Dec; 34(12):2829-2841. PubMed ID: 28948461 [TBL] [Abstract][Full Text] [Related]
19. Multifunctional nanoparticles co-delivering EZH2 siRNA and etoposide for synergistic therapy of orthotopic non-small-cell lung tumor. Yuan ZQ; Chen WL; You BG; Liu Y; Yang SD; Li JZ; Zhu WJ; Zhou XF; Liu C; Zhang XN J Control Release; 2017 Dec; 268():198-211. PubMed ID: 29061511 [TBL] [Abstract][Full Text] [Related]
20. Photo-tearable tape close-wrapped upconversion nanocapsules for near-infrared modulated efficient siRNA delivery and therapy. Zhang Y; Ren K; Zhang X; Chao Z; Yang Y; Ye D; Dai Z; Liu Y; Ju H Biomaterials; 2018 May; 163():55-66. PubMed ID: 29452948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]